1. MiR‐133a‐3p attenuates resistance of non‐small cell lung cancer cells to gefitinib by targeting SPAG5
   Qing Li et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
2. MicroRNA-133a-3p Inhibits Lung Adenocarcinoma Development and Cisplatin Resistance through Targeting GINS4
   Yafu Zhou et al, 2024, Cells Tissues Organs CrossRef
3. Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients
   Mouadh Barbirou et al, 2022, Current Issues in Molecular Biology CrossRef
4. Exosomal miR-133a-3p promotes the growth and metastasis of lung cancer cells following incomplete microwave ablation
   Xia Yang et al, 2023, International Journal of Hyperthermia CrossRef
5. ANGPTL4, a direct target of hsa-miR-133a-3p, accelerates lung adenocarcinoma lipid metabolism, proliferation and invasion
   Qihao Hu et al, 2023, Aging CrossRef
6. MiRNA-375 inhibits retinoblastoma progression through targeting ERBB2 and inhibiting MAPK1/MAPK3 signalling pathway
   Lei Liu et al, 2022, Cutaneous and Ocular Toxicology CrossRef
7. A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay
   Ahmed S. Doghish et al, 2022, Pathology - Research and Practice CrossRef